Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	112.15	127.6	110.53	225.26	589.43
Short-Term Investments	-	1,175	1,352	1,036	245.31	-
Trading Asset Securities	-	-	-	-	-	32.51
Cash & Short-Term Investments	1,592	1,287	1,479	1,146	470.57	621.94
Cash Growth	104.56%	-12.98%	29.06%	143.59%	-24.34%	56.21%
Accounts Receivable	-	131.76	109.51	208.72	155.77	126.64
Other Receivables	-	-	-	-	-	15.37
Receivables	-	131.76	109.51	208.72	155.77	142.01
Inventory	-	152	149.97	206.76	297.42	297.25
Prepaid Expenses	-	16.62	16.02	10.68	10.62	-
Other Current Assets	-	24.24	212.95	73.17	156.43	143.58
Total Current Assets	-	1,612	1,968	1,646	1,091	1,205
Property, Plant & Equipment	-	88.37	93.02	242.78	225.73	233.47
Long-Term Investments	-	168.62	47	33.84	290.55	120.58
Goodwill	-	96.93	-	-	0.3	0.3
Other Intangible Assets	-	759.24	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	23.45
Other Long-Term Assets	-	57.5	62.97	27.25	34.86	59.45
Total Assets	-	2,783	2,171	1,949	1,642	1,642
Accounts Payable	-	97.34	75.96	165.8	185.5	180.5
Accrued Expenses	-	101.99	74.19	88.86	79.86	89.37
Short-Term Debt	-	-	-	-	-	67.88
Current Portion of Leases	-	16.07	13.84	7.54	-	-
Current Income Taxes Payable	-	-	-	0.19	2.33	38.22
Current Unearned Revenue	-	9.1	12.94	6.12	-	-
Other Current Liabilities	-	34.54	14.35	7.2	2.03	28
Total Current Liabilities	-	259.04	191.28	275.71	269.72	403.97
Long-Term Leases	-	76.32	75.57	52.47	-	-
Pension & Post-Retirement Benefits	-	-	-	-	-	0.18
Long-Term Deferred Tax Liabilities	-	30.7	20.73	21.63	32.38	18.59
Other Long-Term Liabilities	-	17.04	9.18	10.75	12.56	-
Total Liabilities	-	383.1	296.76	360.56	314.66	422.73
Common Stock	-	132.8	132.19	130.99	130.99	130.99
Additional Paid-In Capital	-	140.56	111.2	6	6	6
Retained Earnings	-	1,906	1,460	1,363	1,112	1,004
Comprehensive Income & Other	-	219.65	170.7	88.52	78.87	78.39
Shareholders' Equity	2,528	2,400	1,874	1,589	1,328	1,219
Total Liabilities & Equity	-	2,783	2,171	1,949	1,642	1,642
Total Debt	88.36	92.39	89.41	60.01	-	67.88
Net Cash (Debt)	1,504	1,195	1,390	1,086	470.57	554.06
Net Cash Growth	121.08%	-14.03%	27.96%	130.84%	-15.07%	65.84%
Net Cash Per Share	22.31	17.75	20.96	16.59	7.18	8.46
Filing Date Shares Outstanding	65.57	66.4	66.09	65.5	65.5	65.5
Total Common Shares Outstanding	65.57	66.4	66.09	65.5	65.5	65.5
Working Capital	-	1,353	1,777	1,370	821.09	800.8
Book Value Per Share	37.80	36.14	28.35	24.26	20.27	18.62
Tangible Book Value	1,711	1,543	1,874	1,589	1,327	1,219
Tangible Book Value Per Share	25.58	23.24	28.35	24.26	20.27	18.61
Land	-	-	-	87.59	87.59	87.59
Buildings	-	-	-	163.8	163.8	160.87
Machinery	-	14.77	20.38	18.02	329.61	328.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.